about
Cancer-testis antigen SLLP1 represents a promising target for the immunotherapy of multiple myelomaGenome-wide immunity studies in the rabbit: transcriptome variations in peripheral blood mononuclear cells after in vitro stimulation by LPS or PMA-IonomycinPro-oncogenic cytokines and growth factors are differentially expressed in the post-surgical wound fluid from malignant compared to benign breast lesionsLevels of interleukin-16 in peripheral blood of 52 patients with multiple myeloma and its clinical significance.High level of interleukin-10 in serum predicts poor prognosis in multiple myeloma.MiRNA-34a overexpression inhibits multiple myeloma cancer stem cell growth in mice by suppressing TGIF2.Role of motility-related protein-1 in promoting the development of several types of cancer (Review).Regulation of cellular processes by interleukin-16 in homeostasis and cancer.RNA interference for multiple myeloma therapy: targeting signal transduction pathways.Oscillating expression of interleukin-16 in multiple myeloma is associated with proliferation, clonogenic growth, and PI3K/NFKB/MAPK activation.PEGylated long-circulating liposomes deliver homoharringtonine to suppress multiple myeloma cancer stem cellsTo b(ortezomib) or not to be: the stroma's the thing.Bortezomib-induced pro-inflammatory macrophages as a potential factor limiting anti-tumour efficacy.Leptin receptor antagonism of iNKT cell function: a novel strategy to combat multiple myeloma.Interleukin-16 polymorphisms as new promising biomarkers for risk of gastric cancer.Genome-scale analysis to identify prognostic markers in patients with early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy.Inflammatory and Anti-Inflammatory Equilibrium, Proliferative and Antiproliferative Balance: The Role of Cytokines in Multiple Myeloma.Role of brain-derived neurotrophic factor in bone marrow angiogenesis in multiple myeloma.Prognostic Value of IL-10 and Its Relationship with Disease Stage in Iranian Patients with Multiple Myeloma
P2860
Q28648164-FAA38F3A-E329-4672-8073-712AE2D0FE65Q35079356-76B0451A-6C0E-427C-B75A-002086408570Q36029913-20937D4C-D95B-4F66-892D-EF979917DF47Q36511611-0A8D292E-2C1B-4CD2-B5E5-C18453F4805EQ36750576-58DB845E-BCFE-41B4-8E2B-CFC78C308419Q37553776-E111B3F8-EBC6-4D7B-ADA2-305DA0C630DAQ37575135-77A5F740-FEE9-46A6-9DFC-A3461E4E7A8AQ38124813-CC917E69-E243-400A-A7D3-323953D9DC9DQ38550480-87EB7DCE-D597-4B15-9BB6-01301002BD92Q38703269-389944D5-F6D2-4368-B2D3-DBB94A261C52Q38722800-AD029796-9DD8-42F1-B45E-FBFEC6E3F322Q38762531-B7497CAD-F451-49AD-BCDF-9CA1DB703B97Q38781397-A5BA11E6-0533-42A1-9111-CF4D1232D945Q38793607-A4445B26-D5C3-44A9-A6AB-6AE6BCB791ACQ41395505-1EA8A792-5125-427E-9A6D-515D1AD0B536Q42273391-93207F56-7416-483C-9C5B-1079FF20C23AQ45756098-F5C856A8-2228-4A28-9C98-E70806609A73Q47886798-AC07D03E-9FC6-442F-94B3-AD075D5C6C90Q49649026-466D6D36-E00C-4452-BE4F-3E87D1804876
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Role of interleukin 16 in multiple myeloma.
@en
Role of interleukin 16 in multiple myeloma.
@nl
type
label
Role of interleukin 16 in multiple myeloma.
@en
Role of interleukin 16 in multiple myeloma.
@nl
prefLabel
Role of interleukin 16 in multiple myeloma.
@en
Role of interleukin 16 in multiple myeloma.
@nl
P2093
P2860
P356
P1476
Role of interleukin 16 in multiple myeloma.
@en
P2093
Andreas H Marx
Axel R Zander
Carsten Bokemeyer
Christiane Keller
Djordje Atanackovic
Henrike Reinhard
Jens Panse
Jozef Zustin
Julia Templin
Katrin Bartels
P2860
P304
P356
10.1093/JNCI/DJS257
P407
P577
2012-06-28T00:00:00Z